Evaluation of the NEUROSWING Orthosis on Walking Speed in a Population With Dorsal and/or Plantar Flexor Deficits, With a View to a Reimbursement Application

NANot yet recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

September 15, 2026

Study Completion Date

September 15, 2026

Conditions
StrokeMultiple SclerosisCerebral PalsyNeuromuscular Deficits
Interventions
DEVICE

NEUROSWING Orthosis (experimental) : carbon orthosis with an active ankle articulation

"The patients will use the experimental device during 14 days straight as well, then a washout period of 7 days with no interventons and then the comparator during 14 days straight. The order in which they will use each device will depend on the groupe they have been randomized in :~* Arm 1 : Control device during 14 days, followed by a 7 day washout period, then exerimental device during 14 days~* Arm 2 : Experimental device during 14 days, followed by a 7 day washout period, then control device during 14 days"

DEVICE

Carbon orthosis (control)

"The patients will use the experimental device during 14 days straight as well, then a washout period of 7 days with no interventons and then the comparator during 14 days straight. The order in which they will use each device will depend on the groupe they have been randomized in :~* Arm 1 : Control device during 14 days, followed by a 7 day washout period, then exerimental device during 14 days~* Arm 2 : Experimental device during 14 days, followed by a 7 day washout period, then control device during 14 days"

Trial Locations (2)

14200

IMPR du Bois de Lébisey, Hérouville-Saint-Clair

37390

CMPR Bel-Air, La Membrolle-sur-Choisille

All Listed Sponsors
collaborator

Pôle Saint Hélier

OTHER

lead

ÖSSUR France

INDUSTRY

NCT07108088 - Evaluation of the NEUROSWING Orthosis on Walking Speed in a Population With Dorsal and/or Plantar Flexor Deficits, With a View to a Reimbursement Application | Biotech Hunter | Biotech Hunter